Kumaraswamy meets PM Modi, discusses Cauvery issue

Bengaluru, May 9: The bar owners in Karnataka, while welcoming the state government's decision to allow takeaway sales of liquor, said that the move is not going to benefit them much.

Venkatesh Babu, a Bengaluru-based bar owner said, "We welcome this move, our bar was closed for two months due to coronavirus crisis. We have been facing losses since then."

"The state government has told us to sell our stocks at maximum retail price (MRP). It is difficult for us to manage as the rent is high and we also have to pay salaries," he added.

The owner of Pingara Bar and Restaurant, Shivamogga said, "The government has said that is for parcel only and that too at MRP. There is no benefit to our business. We are only clearing the existing stock. They have given us time till May 17 and are not even giving us fresh stock. We are only allowed to sell what we have already."

Karnataka government in its Friday order allowed restaurants, pubs and bars to sell liquor at retail prices from May 9 till May 17, the day the third phase of lockdown is slated to end.

Earlier, the government had allowed the opening of liquor shops in order to mobilise revenue.

However, bars, pubs, restaurants were ordered to remain closed amid the COVID-19 lockdown.

Shivamogga, Jun 30: The organic farmers' market in Shivamogga in Karnataka has seen a rise in the demand for organic fruits and vegetables in the midst of the COVID-19 pandemic.

Residents of nearby areas frequently visit the market to get fresh produce.

According to Sridhar, a farmer who sells his produce in the market, the demand for organic fruits and vegetables was very low before the coronavirus outbreak.

"I have been involved in organic farming for the last two decades but there was no real market. Since these days everyone is trying to boost their immunity, we are getting a lot of positive response from the locals," he told news agency.

Sridhar and other farmers come from villages near the city. They are authentic organic farmers under the Vikas Trust and Savayava Krishi Parivar, a federation of organic farmer's families based in Karnataka, and they promote pesticide and fertiliser free agriculture.

Gurumel Singh, who often comes to the local market said, "My family has started eating more organic fruits and vegetable now because of the pandemic. We have been told it is important to take care of our health and organic fruits and vegetables are good immunity boosters. The fruits I buy from the organic market are also much sweeter than the ones I get elsewhere."

University of Oxford researchers have claimed that a cheap and widely available drug called dexamethasone can help save the lives of patients who are seriously ill with coronavirus.

Scientists working on the Recovery Trial found the drug could help patients on ventilators and oxygen, but had no effect on those who did not need help breathing.

“Based on these results, one death would be prevented by treatment of around eight ventilated patients or around 25 patients requiring oxygen alone,” researchers said in a statement.

Matt Hancock, the health secretary, tweeted: “This global first exemplifies the power of science.”

“I’m absolutely delighted that today we can announce the first successful clinical trial for a treatment for Covid-19,” Mr Hancock said.

Recovery Trial experts said a randomised group of 2,104 patients was given 6mg of dexamethasone per day for 10 days, while another group of 4,321 were given normal treatment.

Dexamethasone reduced deaths by one-fifth in patients on oxygen feeds and by one-third in those who needed a ventilator to breathe, preliminary results showed.

Mr Hancock added: “This is a huge step forward and it’s because we’ve backed the science.”

Martin Landray, professor of medicine and epidemiology at the Nuffield Department of Population Health, University of Oxford, and one of the trial’s chief investigators, said in a statement: “These preliminary results from the Recovery Trial are very clear – dexamethasone reduces the risk of death among patients with severe respiratory complications.

“Covid-19 is a global disease – it is fantastic that the first treatment demonstrated to reduce mortality is one that is instantly available and affordable worldwide.”